3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
5
Medulloblastoma
3
Colonic Neoplasms
3
Turcot syndrome
2
Triple Negative Breast Neoplasms
2
Rhabdoid Tumor
2
Recurrence
2
Pinealoma
2
Neuroblastoma
2
Ependymoma
2
Carcinoma
2
Urinary Bladder Neoplasms
1
Solid Tumor
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Pancreatic Cancer Metastatic
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Mouth Neoplasms
1
Melanoma
1
Locally Advanced Rectal Cancer
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Interventions
Lenalidomide
7
Dexamethasone
5
daratumumab
4
Calcium Dobesilate
4
dexamethasone acetate
3
dexamethasone 21-phosphate
3
auricularum
3
Curcumin
3
isatuximab
2
iberdomide
2
Leflunomide
2
pomalidomide
1
poly ICLC
1
piperine
1
pembrolizumab
1
ixazomib
1
fludarabine phosphate
1
fludarabine
1
citarinostat
1
Watchful Waiting
1
Urination
1
Stem Cell Transplantation
1
Resistance Training
1
Propranolol
1
Probiotics
1
Peripheral Blood Stem Cell Transplantation
1
PVX-410 vaccine
1
Observation
1
Metformin
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Smoldering Multiple Myeloma
×
Celecoxib
×
1 year
×
Clear all
No trials found.